Bayer Acquires Animal Health Company in New Zealand

Bayer says it has agreed to buy the Bomac Group (Auckland), a privately owned animal health company with 290 products, targeting food animals in particular. Through this acquisition Bayer strengthens its animal health business with special emphasis on emerging markets in the southern hemisphere. Bomac's main focus is on the treatment of mastitis with dairy cattle and parasiticides in sheep. Bayer says it also aims to benefit from Bomac's R&D expertise, especially in the field of mastitis management and parasite control. Financial details of the transaction...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers